selegiline has been researched along with ADDH in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Birkenhager, TK; Caiazza, C; Cattaneo, CI; de Bartolomeis, A; Fornaro, M; Gillman, K; Iasevoli, F; Rossano, F; Ruhé, HG; Sobrino, A; Solini, N; Stahl, S; Van den Eynde, V; Vellucci, A; Zotti, N | 1 |
| Osland, ST; Pringsheim, T; Steeves, TD | 1 |
| Brown, JA; Diggs-Andrews, KA; Gutmann, DH; Mach, RH; Wozniak, DF; Xu, J | 1 |
| Akhondzadeh, S; Amini, H; Arabgol, F; Davari-Ashtiani, R; Tavakolian, R | 1 |
| Alaghband-Rad, J; Ghanizadeh, A; Mesgarpour, B; Mohammadi, MR; Soori, H; Tehranidoost, M | 1 |
| Logan, WJ; Malone, MA; Roberts, W; Rubinstein, S | 1 |
| Levin-Epstein, M | 1 |
| Riddle, MA; Scahill, LD; Walkup, JT | 1 |
| Jankovic, J | 1 |
| Beach, J; Brower, CA; Chapieski, L; Como, P; Dimitsopulos, T; Feigin, A; Jankovic, J; Kurlan, R; McDermott, MP; Trinidad, K | 1 |
| Cohen, RM; Ernst, M; Jons, PH; Liebenauer, LL; Tebeka, D; Zametkin, AJ | 1 |
| Eisenhofer, G; Ernst, M; Jons, PH; Liebenauer, LL; Murphy, DL; Tebeka, D; Zametkin, AJ | 1 |
| Behar, D; Schaller, JL | 1 |
| Berlin, F; Breakefield, XO; Eisenhofer, G; Ernst, M; George, T; Greenberg, BD; Murphy, DL; Sims, K; Zametkin, A | 1 |
| Boix, F; Kolpus, T; Qiao, SW; Sagvolden, T | 1 |
| García-Ruiz, PJ; Jiménez-Jiménez, FJ | 1 |
| Reimherr, FW; Wender, PH; Wood, DR | 1 |
| Donnelly, M; Ismond, D; Rapoport, JL; Zametkin, A | 1 |
6 review(s) available for selegiline and ADDH
| Article | Year |
|---|---|
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations.
Topics: Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Selegiline | 2023 |
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders | 2018 |
Selegiline-transdermal--Somerset: Emsam.
Topics: Administration, Cutaneous; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Depressive Disorder; Drugs, Investigational; Humans; Selegiline | 2003 |
Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Clonidine; Comorbidity; Dextroamphetamine; Guanfacine; Humans; Learning Disabilities; Methylphenidate; Pemoline; Selegiline; Tourette Syndrome | 1995 |
Pharmacological options for the treatment of Tourette's disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Botulinum Toxins; Calcium Channel Blockers; Clonidine; Conduct Disorder; Dopamine Antagonists; Humans; Monoamine Oxidase Inhibitors; Selegiline; Tourette Syndrome | 2001 |
New drug trials in attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; Desipramine; Dextroamphetamine; Double-Blind Method; Fenfluramine; Humans; Male; Selegiline; Tranylcypromine | 1985 |
7 trial(s) available for selegiline and ADDH
| Article | Year |
|---|---|
Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
Topics: Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Methylphenidate; Selegiline | 2003 |
Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial.
Topics: Adolescent; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Headache; Humans; Male; Methylphenidate; Selegiline | 2004 |
Placebo-controlled study examining effects of selegiline in children with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Child; Cross-Over Studies; Double-Blind Method; Female; Humans; Learning; Male; Monoamine Oxidase Inhibitors; Motor Activity; Selegiline; Social Behavior; Treatment Outcome | 2006 |
A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Selegiline; Tourette Syndrome; Treatment Outcome | 1996 |
Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Dizziness; Female; Humans; Male; Monoamine Oxidase Inhibitors; Selegiline | 1996 |
Selegiline in ADHD adults: plasma monoamines and monoamine metabolites.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Psychomotor Performance; Selegiline; Serotonin | 1997 |
New drug trials in attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; Desipramine; Dextroamphetamine; Double-Blind Method; Fenfluramine; Humans; Male; Selegiline; Tranylcypromine | 1985 |
7 other study(ies) available for selegiline and ADDH
| Article | Year |
|---|---|
PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Carbon Radioisotopes; Corpus Striatum; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Drug Evaluation, Preclinical; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Neurofibromatosis 1; Neuroprotective Agents; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Selegiline | 2011 |
A new way to deliver psychiatric meds.
Topics: Administration, Cutaneous; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Selegiline; United States | 2006 |
Deprenyl in attention deficit associated with Tourette's syndrome.
Topics: Abdominal Pain; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Female; Headache; Humans; Male; Selegiline; Sleep Stages; Tic Disorders; Tourette Syndrome | 1993 |
Selegiline for the delivery of small doses of amphetamine.
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Child Development Disorders, Pervasive; Humans; Intellectual Disability; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Selegiline | 1997 |
Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
Topics: Adolescent; Adult; Aged; Animals; Attention Deficit Disorder with Hyperactivity; Chromosome Deletion; Chromosome Mapping; Domestic Violence; Humans; Isoenzymes; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reference Values; Risk Assessment; Selegiline; Sex Offenses; X Chromosome | 1998 |
Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder.
Topics: Animals; Appetitive Behavior; Attention Deficit Disorder with Hyperactivity; Brain; Disease Models, Animal; Dopamine; Impulsive Behavior; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reinforcement Schedule; Selegiline; Serotonin; Species Specificity | 1998 |
Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Humans; Methylphenidate; Pargyline; Pemoline; Phenethylamines; Selegiline | 1985 |